Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 5:8:e55023.
doi: 10.2196/55023.

Digital Health Program to Support Family Caregivers of Children Undergoing Growth Hormone Therapy: Qualitative Feasibility Study

Affiliations

Digital Health Program to Support Family Caregivers of Children Undergoing Growth Hormone Therapy: Qualitative Feasibility Study

Alba Jiménez-Díaz et al. JMIR Pediatr Parent. .

Erratum in

Abstract

Background: Caregivers of children with growth hormone deficiency often face emotional challenges (eg, stress) associated with their children's health conditions. This psychological burden might affect children's adherence to treatment and hinder their health-related quality of life (HrQoL). This assumption is leading to seriously considering multidimensional clinical approaches to pediatric health conditions where the emotional well-being of caregivers should be accounted for to optimize children's health outcomes. Novel mobile health (mHealth) solutions based on emotional and behavioral change techniques can play a promising role because they are increasingly used within different health areas to support adaptive psychological functioning. However, whether and how mHealth solutions of this type of emotional well-being support caregivers of children with growth-related problems is an issue that needs to be clarified.

Objective: This study aimed to gather qualitative information to better understand individualized experiences of caregiving of children undergoing growth hormone therapy (GHt) and perceived barriers or facilitators for the adoption of an mHealth solution called Adhera Caring Digital Program (ACDP).

Methods: A total of 10 family caregivers were recruited at Miguel Servet Children's Hospital, and they engaged with the ACDP for 1 month. The ACDP is a mobile-based digital intervention focused on promoting the overall well-being of family caregivers which provides access to personalized education, motivational mobile-based messages, and mental well-being exercises such as mindfulness or respiratory exercises. Subsequently, an individual semistructured interview was performed to gather qualitative user experience information.

Results: The digital intervention was well-received. The ACDP was found to be useful, easy to use, and understandable, addressing all the difficulties expressed by caregivers. It was also noted to be particularly helpful at the beginning of the treatment and, for some families, became a natural tool that strengthened the parent-child relationship.

Conclusions: The ACDP is a promising and well-accepted tool that enhances the experience of patients and caregivers. It improves the management of growth hormone deficiency and promotes the overall well-being of family caregivers.

Trial registration: ClinicalTrials NCT04812665; https://clinicaltrials.gov/study/NCT04812665.

International registered report identifier (irrid): RR2-10.1186/s12911-022-01935-1.

Keywords: behavioral change; caregivers; children; digital health; feasibility study; growth hormone deficiency; health condition; mHealth; mobile Health; mobile based solutions; parent-child relationship; pediatric; psychological burden; quality of life; technology acceptance; therapy; wellbeing.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: This study is about a digital solution developed and commercialized by Adhera Health. Adhera Health, AA, and OR-R have other collaborations with Merck Healthcare KGaA beyond this study.

Figures

Figure 1
Figure 1
An Educational Unit within the app.
Figure 2
Figure 2
Categories or themes identified in the interviews. GHD: growth hormone deficiency.

Similar articles

References

    1. Dattani MT, Malhotra N. A review of growth hormone deficiency. Paediatrics and Child Health. 2019;29(7):285–292. doi: 10.1016/j.paed.2019.04.001. - DOI
    1. Ranke MB, Wit JM. Growth hormone - past, present and future. Nat Rev Endocrinol. 2018;14(5):285–300. doi: 10.1038/nrendo.2018.22.nrendo.2018.22 - DOI - PubMed
    1. Cutfield WS, Derraik JGB, Gunn AJ, Reid K, Delany T, Robinson E, Hofman PL. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One. 2011;6(1):e16223. doi: 10.1371/journal.pone.0016223. https://dx.plos.org/10.1371/journal.pone.0016223 - DOI - DOI - PMC - PubMed
    1. Savage MO, Fernandez-Luque L, Graham S, van Dommelen P, Araujo M, de Arriba A, Koledova E. Adherence to r-hGH therapy in pediatric growth hormone deficiency: current perspectives on how patient-generated data will transform r-hGH treatment towards integrated care. Patient Prefer Adherence. 2022;16:1663–1671. doi: 10.2147/PPA.S271453. https://europepmc.org/abstract/MED/35846871 271453 - DOI - PMC - PubMed
    1. Fisher BG, Acerini CL. Understanding the growth hormone therapy adherence paradigm: a systematic review. Horm Res Paediatr. 2013;79(4):189–196. doi: 10.1159/000350251. https://doi.org/10.1159/000350251 000350251 - DOI - DOI - PubMed

Associated data

LinkOut - more resources